Company intelligence / Profile preview

MOLLI Surgical

Toronto, Ontario, Canada

Ownership: Private
Employees: ~50
Development stage: Other

Overview

The MOLLI 2 System, including the MOLLI Marker, OncoPen, and MOLLI re.markable tools, is commercially available and used clinically for wire-free, radiation-free localization of breast lesions during surgery, reportedly improving accuracy, surgical workflow, and patient experience[1][5][6].

Therapeutic areas: Oncology
Modalities: DeviceMedical Device
Industry: Surgical Medical Devices

Partnerships

MUSC Hollings Cancer CenterHillcrest Medical Center

Beyond the preview

Go deeper on MOLLI Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MOLLI Surgical.

Explore the full profile